AIM ImmunoTech (AIM) Gross Margin (QoQ) (2010 - 2026)
AIM ImmunoTech (AIM) Gross Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.42 Mn | -5.55 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -105.00 |
| Mar 31, 2026 | 17,229.00 |
| Dec 31, 2025 | 7,106.00 |
| Sep 30, 2025 | -22,154.00 |
| Jun 30, 2025 | 2,250.00 |
| Mar 31, 2025 | -4,694.00 |
| Dec 31, 2024 | 730.00 |
| Sep 30, 2024 | -686.00 |
| Jun 30, 2024 | 400.00 |
| Mar 31, 2024 | -154.00 |
| Dec 31, 2023 | 4,676.00 |
| Jun 30, 2022 | 333.00 |
| Mar 31, 2022 | 11,867.00 |
| Dec 31, 2021 | 12,376.00 |
| Sep 30, 2021 | 73,729.00 |
| Jun 30, 2021 | -36,661.00 |
| Mar 31, 2021 | -37,500.00 |
| Dec 31, 2020 | 9,524.00 |
| Sep 30, 2020 | -6,667.00 |
| Jun 30, 2020 | -4,667.00 |